Association Between Renal Reserve Function and Progression of Renal Function to Predict CKD Risk in Thai Elderly
Study of the Association Between Renal Reserve Function and Progression of Renal Function to Predict Chronic Kidney Disease Risk in Thai Elderly
1 other identifier
observational
100
1 country
1
Brief Summary
This study investigates renal functional reserve in elderly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 24, 2019
CompletedFirst Submitted
Initial submission to the registry
December 2, 2021
CompletedFirst Posted
Study publicly available on registry
December 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedDecember 15, 2021
September 1, 2021
2.7 years
December 2, 2021
December 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of renal functional reserve per 12 months (mL/min)
Renal functional reserve defined as the difference between baseline creatinine clearance and creatinine clearance achieved under stimulation with amino acid infusion.
12 months
Eligibility Criteria
Elders age more than 60 years who are non-frail and has no limited life expectancy
You may qualify if:
- Patient age \> 60 years at screening
- Patient willing to participate in the study and can provide inform consent
- Patient have residual kidney function ≤ 90 ml/min/1.73m2 by CKD-EPI equation
You may not qualify if:
- Patient active smoking
- Patient have Charlson comorbidity index \> .....
- Patient active cancer
- Patient contraindications for blood collection
- Patients with a history of hypersensitivity to cimetidine or amino acid IV solution
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kearkiat Praditpornsilpa
Bangkok, 10330, Thailand
Biospecimen
Serum
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
December 2, 2021
First Posted
December 15, 2021
Study Start
October 24, 2019
Primary Completion
June 30, 2022
Study Completion
December 30, 2022
Last Updated
December 15, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share